Emmaus Life Scie Financials
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Emmaus Life Scie has an operating margin of -11.4%, meaning the company retains $-11 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from 12.0% the prior year.
Emmaus Life Scie's revenue declined 43.7% year-over-year, from $29.6M to $16.7M. This contraction results in a growth score of 0/100.
Emmaus Life Scie's current ratio of 0.11 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 0/100, which could limit financial flexibility.
While Emmaus Life Scie generated -$2.3M in operating cash flow, capex of $12K consumed most of it, leaving -$2.3M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Emmaus Life Scie passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Emmaus Life Scie generates $0.35 in operating cash flow (-$2.3M OCF vs -$6.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Emmaus Life Scie earns $-0.3 in operating income for every $1 of interest expense (-$1.9M vs $5.5M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
This page shows Emmaus Life Scie (EMMA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Emmaus Life Scie generated $16.7M in revenue in fiscal year 2024. This represents a decrease of 43.7% from the prior year.
Emmaus Life Scie's EBITDA was -$1.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 152.4% from the prior year.
Emmaus Life Scie generated -$2.3M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 51.2% from the prior year.
Emmaus Life Scie reported -$6.5M in net income in fiscal year 2024. This represents a decrease of 72.9% from the prior year.
Emmaus Life Scie earned $-0.10 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 42.9% from the prior year.
Emmaus Life Scie held $1.4M in cash against $29.0M in long-term debt as of fiscal year 2024.
Emmaus Life Scie had 64M shares outstanding in fiscal year 2024. This represents an increase of 3.3% from the prior year.
Emmaus Life Scie's gross margin was 92.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 2.7 percentage points from the prior year.
Emmaus Life Scie's operating margin was -11.4% in fiscal year 2024, reflecting core business profitability. This is down 23.3 percentage points from the prior year.
Emmaus Life Scie's net profit margin was -38.8% in fiscal year 2024, showing the share of revenue converted to profit. This is down 26.1 percentage points from the prior year.
Emmaus Life Scie invested $657K in research and development in fiscal year 2024. This represents a decrease of 44.7% from the prior year.
Emmaus Life Scie invested $12K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 29.4% from the prior year.
EMMA Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.4M+19.9% | $2.8M+17.1% | $2.4M-26.9% | $3.3M-38.8% | $5.4M+114.6% | $2.5M-64.5% | $7.1M+40.8% | $5.0M |
| Cost of Revenue | $247K+64.7% | $150K-33.3% | $225K-27.2% | $309K+28.2% | $241K-6.2% | $257K+34.6% | $191K-10.7% | $214K |
| Gross Profit | $3.1M+17.4% | $2.7M+22.3% | $2.2M-26.9% | $3.0M-41.9% | $5.1M+128.4% | $2.2M-67.3% | $6.9M+43.1% | $4.8M |
| R&D Expenses | $50K-10.7% | $56K-68.2% | $176K+28.5% | $137K-28.3% | $191K+4.4% | $183K+10.2% | $166K-59.9% | $414K |
| SG&A Expenses | $1.7M-25.0% | $2.3M-1.4% | $2.3M+2.3% | $2.3M-16.3% | $2.7M-4.8% | $2.9M-6.4% | $3.1M+6.8% | $2.9M |
| Operating Income | $695K+287.8% | -$370K+62.2% | -$980K-75.9% | -$557K-195.7% | $582K+121.2% | -$2.7M-302.2% | $1.4M+5545.8% | $24K |
| Interest Expense | $1.9M+15.1% | $1.7M+33.6% | $1.3M-1.7% | $1.3M+32.3% | $966K-49.4% | $1.9M-12.3% | $2.2M+14.1% | $1.9M |
| Income Tax | $579K+198.1% | -$590K-14850.0% | $4K-33.3% | $6K-80.6% | $31K+542.9% | -$7K+93.8% | -$112K-394.7% | $38K |
| Net Income | -$2.1M-82.9% | -$1.1M+51.3% | -$2.3M-33.3% | -$1.7M+20.0% | -$2.2M+49.8% | -$4.3M-459.6% | $1.2M+1704.5% | $67K |
| EPS (Diluted) | $-0.03-50.0% | $-0.02+50.0% | $-0.04-33.3% | $-0.030.0% | $-0.03+57.1% | $-0.07-275.0% | $0.04+500.0% | $-0.01 |
EMMA Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.8M-11.1% | $23.3M+3.9% | $22.5M-4.8% | $23.6M-9.0% | $25.9M-12.2% | $29.5M-16.0% | $35.2M-25.9% | $47.5M |
| Current Assets | $4.8M-4.6% | $5.0M-11.3% | $5.7M-16.5% | $6.8M-24.9% | $9.0M+14.9% | $7.8M-31.8% | $11.5M+24.3% | $9.3M |
| Cash & Equivalents | $293K-66.9% | $886K-33.5% | $1.3M-4.0% | $1.4M-8.9% | $1.5M-10.9% | $1.7M-32.8% | $2.5M+69.2% | $1.5M |
| Inventory | $1.2M-7.6% | $1.3M-8.6% | $1.4M-12.1% | $1.6M+0.4% | $1.6M+6.6% | $1.5M-10.8% | $1.7M+3.7% | $1.6M |
| Accounts Receivable | $2.6M+26.5% | $2.1M+0.5% | $2.1M-21.4% | $2.6M-43.0% | $4.6M+53.8% | $3.0M-45.9% | $5.5M+20.4% | $4.6M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $80.2M+1.5% | $79.0M-2.5% | $81.1M+1.2% | $80.1M-3.5% | $83.0M-0.3% | $83.2M+0.3% | $82.9M-1.0% | $83.8M |
| Current Liabilities | $64.2M+3.4% | $62.1M-4.4% | $64.9M+2.1% | $63.6M-0.7% | $64.0M+2.6% | $62.4M+1.5% | $61.5M+1.0% | $60.9M |
| Long-Term Debt | $29.1M-2.2% | $29.7M+2.5% | $29.0M+0.1% | $29.0M-1.4% | $29.4M-0.2% | $29.4M-3.7% | $30.6M-6.0% | $32.5M |
| Total Equity | -$59.5M-6.8% | -$55.7M+4.9% | -$58.6M-3.8% | -$56.5M+0.9% | -$57.0M-6.3% | -$53.6M-12.3% | -$47.8M-31.5% | -$36.3M |
| Retained Earnings | -$268.1M-0.8% | -$266.0M-0.4% | -$264.9M-0.9% | -$262.6M0.0% | -$262.7M-0.8% | -$260.5M-1.7% | -$256.1M+0.5% | -$257.3M |
EMMA Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $409K+114.1% | -$2.9M-1142.3% | $279K-18.7% | $343K+111.8% | -$2.9M-2183.6% | $140K-86.5% | $1.0M+1686.2% | $58K |
| Capital Expenditures | $0 | N/A | N/A | $6K+100.0% | $3K-25.0% | $4K-33.3% | $6K | $0 |
| Free Cash Flow | $409K | N/A | N/A | $337K+111.5% | -$2.9M-2247.1% | $136K-86.8% | $1.0M+1675.9% | $58K |
| Investing Cash Flow | $0 | N/A | N/A | -$2K-100.1% | $2.5M+62725.0% | -$4K+33.3% | -$6K+98.5% | -$399K |
| Financing Cash Flow | -$1.0M-452.8% | $284K+182.3% | -$345K-76.9% | -$195K-183.0% | $235K+124.6% | -$955K-19000.0% | -$5K-101.0% | $494K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EMMA Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 92.7%-2.0pp | 94.7%+4.0pp | 90.6%+0.0pp | 90.6%-4.9pp | 95.5%+5.8pp | 89.7%-7.6pp | 97.3%+1.6pp | 95.7% |
| Operating Margin | 20.6%+33.7pp | -13.1%+27.6pp | -40.7%-23.8pp | -16.9%-27.7pp | 10.8%+120.2pp | -109.3%-128.5pp | 19.2%+18.7pp | 0.5% |
| Net Margin | -61.5%-21.2pp | -40.3%+56.6pp | -96.8%-43.7pp | -53.1%-12.5pp | -40.6%+132.9pp | -173.5%-190.6pp | 17.1%+15.8pp | 1.3% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -10.0%-5.1pp | -4.9%+5.5pp | -10.4%-3.0pp | -7.4%+1.0pp | -8.4%+6.3pp | -14.7%-18.2pp | 3.4%+3.3pp | 0.1% |
| Current Ratio | 0.070.0 | 0.080.0 | 0.09-0.0 | 0.11-0.0 | 0.14+0.0 | 0.13-0.1 | 0.19+0.0 | 0.15 |
| Debt-to-Equity | -0.49+0.0 | -0.53-0.0 | -0.49+0.0 | -0.510.0 | -0.52+0.0 | -0.55+0.1 | -0.64+0.3 | -0.89 |
| FCF Margin | 12.1% | N/A | N/A | 10.2%+64.6pp | -54.3%-59.7pp | 5.4%-9.1pp | 14.6%+13.4pp | 1.2% |
Note: Shareholder equity is negative (-$56.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.11), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Emmaus Life Scie's annual revenue?
Emmaus Life Scie (EMMA) reported $16.7M in total revenue for fiscal year 2024. This represents a -43.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Emmaus Life Scie's revenue growing?
Emmaus Life Scie (EMMA) revenue declined by 43.7% year-over-year, from $29.6M to $16.7M in fiscal year 2024.
Is Emmaus Life Scie profitable?
No, Emmaus Life Scie (EMMA) reported a net income of -$6.5M in fiscal year 2024, with a net profit margin of -38.8%.
What is Emmaus Life Scie's earnings per share (EPS)?
Emmaus Life Scie (EMMA) reported diluted earnings per share of $-0.10 for fiscal year 2024. This represents a -42.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Emmaus Life Scie's EBITDA?
Emmaus Life Scie (EMMA) had EBITDA of -$1.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Emmaus Life Scie have?
As of fiscal year 2024, Emmaus Life Scie (EMMA) had $1.4M in cash and equivalents against $29.0M in long-term debt.
What is Emmaus Life Scie's gross margin?
Emmaus Life Scie (EMMA) had a gross margin of 92.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Emmaus Life Scie's operating margin?
Emmaus Life Scie (EMMA) had an operating margin of -11.4% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Emmaus Life Scie's net profit margin?
Emmaus Life Scie (EMMA) had a net profit margin of -38.8% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Emmaus Life Scie's free cash flow?
Emmaus Life Scie (EMMA) generated -$2.3M in free cash flow during fiscal year 2024. This represents a -51.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Emmaus Life Scie's operating cash flow?
Emmaus Life Scie (EMMA) generated -$2.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Emmaus Life Scie's total assets?
Emmaus Life Scie (EMMA) had $23.6M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Emmaus Life Scie's capital expenditures?
Emmaus Life Scie (EMMA) invested $12K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Emmaus Life Scie spend on research and development?
Emmaus Life Scie (EMMA) invested $657K in research and development during fiscal year 2024.
How many shares does Emmaus Life Scie have outstanding?
Emmaus Life Scie (EMMA) had 64M shares outstanding as of fiscal year 2024.
What is Emmaus Life Scie's current ratio?
Emmaus Life Scie (EMMA) had a current ratio of 0.11 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Emmaus Life Scie's debt-to-equity ratio?
Emmaus Life Scie (EMMA) had a debt-to-equity ratio of -0.51 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Emmaus Life Scie's return on assets (ROA)?
Emmaus Life Scie (EMMA) had a return on assets of -27.3% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Emmaus Life Scie's cash runway?
Based on fiscal year 2024 data, Emmaus Life Scie (EMMA) had $1.4M in cash against an annual operating cash burn of $2.3M. This gives an estimated cash runway of approximately 7 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Emmaus Life Scie's debt-to-equity ratio negative or unusual?
Emmaus Life Scie (EMMA) has negative shareholder equity of -$56.5M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Emmaus Life Scie's Piotroski F-Score?
Emmaus Life Scie (EMMA) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Emmaus Life Scie's earnings high quality?
Emmaus Life Scie (EMMA) has an earnings quality ratio of 0.35x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Emmaus Life Scie cover its interest payments?
Emmaus Life Scie (EMMA) has an interest coverage ratio of -0.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Emmaus Life Scie?
Emmaus Life Scie (EMMA) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.